| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |